Compare GOSS & BHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GOSS | BHK |
|---|---|---|
| Founded | 2015 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 796.2M | 687.6M |
| IPO Year | 2019 | N/A |
| Metric | GOSS | BHK |
|---|---|---|
| Price | $2.89 | $9.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $8.60 | N/A |
| AVG Volume (30 Days) | ★ 4.4M | 188.3K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.34% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $44,051,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.41 | N/A |
| P/E Ratio | ★ N/A | $10.42 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.76 | $9.02 |
| 52 Week High | $3.87 | $11.09 |
| Indicator | GOSS | BHK |
|---|---|---|
| Relative Strength Index (RSI) | 39.59 | 48.33 |
| Support Level | $3.04 | $9.53 |
| Resistance Level | $3.87 | $9.65 |
| Average True Range (ATR) | 0.29 | 0.06 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 1.49 | 52.50 |
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its managed assets in bonds that are investment-grade quality at the time of investment. The trust's investments will include a broad range of bonds, including corporate bonds, U.S. government and agency securities and mortgage-related securities.